(Commonwealth) _ Croda International Plc, renowned for its smart science-driven solutions, has achieved a significant milestone with the inauguration of its Global Technical Centre in Genome Valley, Hyderabad. Led by Daniele Piergentili, President of Life Sciences, the opening ceremony marks an important step for Croda, expanding its capacity to deliver advanced and sustainable solutions to the pharmaceutical industry. This establishment further solidifies Croda’s presence in Telangana, a key hub supporting India’s position as the global ‘Pharmacy of the World.’ The technical centre, focused on research and development, will foster collaboration, address formulation challenges, and accelerate drug development processes.
They signify the company’s commitment to innovation in the pharmaceutical sector. Genome Valley, a renowned life sciences cluster, provides a conducive environment for research and development activities. This strategic location enhances access to cutting-edge research, talent, and collaborative opportunities with key players in the pharmaceutical industry. The centre will serve as a hub for the creation of new ingredients, the generation of application data, and training for small molecule and biological applications. Its presence in Genome Valley reinforces Croda’s dedication to advancing drug development in Asia and enables close collaboration with customers to develop state-of-the-art drug delivery technologies.
With its pharmaceutical customers, they want to promote cooperative relationships. By engaging in close collaboration, the facility will address formulation challenges and expedite troubleshooting during the development process. The centre’s team of experts will work closely with customers to understand their unique requirements, co-create innovative solutions, and optimize drug formulations. This collaborative approach will enable Croda to provide tailor-made solutions that meet the specific needs of its customers, facilitating efficient drug development and enhancing patient outcomes. The facility’s advanced capabilities, coupled with its proximity to customers and research institutions in Genome Valley, will create a fertile ground for accelerated innovation and breakthrough advancements in the pharmaceutical industry.
Croda International places utmost importance on the safety and well-being of its employees. The newly inaugurated Global Technical Centre has been meticulously designed and constructed to adhere to Croda’s stringent safety standards. The facility incorporates state-of-the-art safety measures, ensuring a secure working environment for all personnel. By prioritizing employee well-being, they aim to foster a culture of excellence and innovation, where its talented workforce can thrive and contribute to the advancement of pharmaceutical science. Through ongoing training and development programs, the company ensures that its employees possess the necessary skills and knowledge to excel in their roles and drive continuous improvement. This focus on safety and employee well-being is a testament to Croda’s commitment to maintaining the highest standards of operational excellence and fostering a positive work environment.
The dedication to quality at Croda International goes beyond small molecules and consumer health products. At the India Biologics & Vaccines Outstanding Industry Awards (BVOIA) 2022, the organization received the coveted “Best Supplier for COVID-19 Vaccine Development” award. This recognition underscores exceptional contributions to the global fight against the pandemic. Throughout the challenging times brought by COVID-19, Croda played a crucial role by providing innovative solutions and technical expertise to support vaccine development. The award not only acknowledges the company’s outstanding work but also serves as a testament to its commitment to making a positive impact on public health. Croda’s dedication to advancing pharmaceutical science and its ability to rise to global challenges have positioned it as a trusted partner in the industry.
Croda International’s inauguration of the Global Technical Centre in Genome Valley, Hyderabad, reinforces its commitment to advancing pharmaceutical innovation. The centre, focused on research and development, will facilitate collaborative partnerships, address formulation challenges, and accelerate drug development processes. Situated in the esteemed Genome Valley, the facility benefits from the vibrant life sciences ecosystem, enabling Croda to tap into cutting-edge research and talent. They foster a culture of excellence and innovation. The company’s recognition for its contributions to COVID-19 vaccine development further exemplifies its dedication to making a positive impact on public health. Croda’s Global Technical Centre is poised to play a pivotal role in shaping the future of pharmaceutical science and contributing to India’s position as a global pharmaceutical leader.
